+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genetic Testing Market Global Forecast 2021-2027, Industry Trends, Growth, Impact of COVID-19, Opportunity Company Analysis

  • ID: 5459144
  • Report
  • October 2021
  • Region: Global
  • 130 Pages
  • Renub Research

FEATURED COMPANIES

  • Abbott Laboratories
  • BioRad Laboratories Inc.
  • F Hoffmann-La Roche AG
  • Illumina Inc.
Genetics is the research of genes, their functions and their impacts. Among the numerous types of genetics such as molecular genetics, population genetics, developmental genetics and quantitative genetics, human genetics deals with the inheritance in human beings. Further, genetic testing is defined as medical devices available in kits and panels used to test genetic diseases in humans. Where in the testing is conducted by accumulating samples of blood of patients. These samples are later run on laboratory machines utilizing test kits

Global Genetic Testing Market is expected to reach US$ 25.05 Billion by 2027


Remarkably, the genetic testing market has experienced rapid growth in the past few years. Prominently, the global genetic testing market is driven by the increasing number of patients with genetic diseases and increasing healthcare expenditure by significant economies across the globe. Besides, the growing awareness about genetic conditions, rising investments in research and development, and increasing government support further fuel the market growth. In addition, the increasing technological advancements from the past few years have opened up several opportunities for market expansion

Suppressing Impact of COVID-19 on the Worldwide Genetic Testing Market


The COVID-19 pandemic has left a notable impact on the growth of the genetic testing market over the crisis. According to the research article issued in Genetics in Medicine 2020, all the clinical genetic testing was limited, and telemedicine-based deliberations and counselling were ratified globally. As per the study, 112 prenatal and 156 clinical genetics/cancer patients were evaluated in one month at the Columbia University Irving Medical Center (CUIMC)

In addition, most genetic testing services have adopted virtualization and home testing kit/home sample collection to oppose the transmission of the SARS-CoV2 virus. Hence, COVID-19 is expected to, directly and indirectly, impact the genetic testing market over the ongoing crisis period

Global Genetic Testing Market Size was US$ 13.92 Billion in 2021


By type, the market comprises Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomics Testing and Nutrigenomic Testing. Diagnostic testing is used to analyze or rule out a precise genetic or chromosomal condition. In multiple cases, genetic testing is employed to declare a diagnosis when a particular disease is doubted based on visible signs and symptoms. Diagnostic testing can be conducted before birth or at any time throughout a person's life but is not possible for all genes or all genetic tones. As per our study, the diagnostic testing segment held the dominant position and is envisioned to persevere its dominance during the forecast period (2021-2027)

Globally Genetic Testing Industry is expected to grow with a CAGR of 10.29% from 2021 to 2027


By technology, the market comprises Cytogenetic Testing, Biochemical Testing and Molecular Testing. Where in molecular testing is the most used technology for genetic testing. Molecular Diagnostics is the latest watchword in the field of Diagnostics and is now touching all areas of medicine. Molecular Diagnostics studies of DNA/RNA of the organism and thus looks at the fundamental unit of disease prediction, detection and cure. For instance, molecular technology is used in genetic tests such as carrier testing, diagnostic testing, predictive & pre-symptomatic testing. On the other hand, as per our analysis, Prenatal and Newborn-Testing also have a significant market share. This is attributable to advancements in awareness regarding healthcare and an increase in the mortality rate from genetic diseases worldwide

Genetic Testing helps in Early Detection of Cancer


By Application - Genetic Testing Market works for Cancer, Genetic Diseases and Cardiovascular Diseases. For cancer, genetic testing helps identify the uncertainty of acquiring various types of cancers during the individual's endurance. Genetic tests are open to testing inherited variants and deviations in the DNA sequence, leading to excessive cells and tumour/cancer growth. For instance, genetic testing for the classification of PALB2 (affiliated with increased uncertainties of breast and pancreatic cancers), BRIP1 (ovarian cancer), CHEK2 (breast and colorectal cancers) and RAD51C and RAD51D (ovarian cancer) are done

The growing burden of cancers universally and the growing consciousness among the global population on precautionary diagnosis and personalized medication are the major factors driving the cancer segment market over the forecast period. Also, the booming technological elevations and product launches anticipate encouraging the studied fragment. For example, in December 2020, Roche launched the Cobas PIK3CA Mutation Test to identify PIK3CA variations in patients with exceptional or metastatic breast cancer. Consequently, the cancer segment is expected to witness significant growth over the forecast period because of the factors mentioned above

United States & Europe are the Leaders in Genetic Testing Industry


By Region, the American market for human genetics is inferable from advancements in diagnostics and medicinal reform and broad utilization of new advances in genetics. Furthermore, the nearness of critical players in the market likewise fills the market development. In recent years, the European market for human genetics has been driven by the rising pervasiveness of various unending hereditary infections and expanding government support for innovative work exercises. In Germany, the most significant market, the increasing spotlight represents the development of research exercises by real market players in genetics and innovative headway

Moreover, the market in the Asia Pacific is energized by the expanding mindfulness about research in congenital infections and consistent ascent in the predominance of hereditary illnesses. Powerful nations adding to the market development are China, Japan, and India because of expanding the accessibility of research offices and nearness of talented workforce, for example, explore researchers and others

The global genetic testing market is highly aggressive, and the prominent players have adopted multiple strategies to garner maximum genetic testing market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market are Abbott Laboratories, Danaher Corporation (Cepheid Inc.), Illumina Inc., BioRad Laboratories Inc. and F Hoffmann-La Roche AG

This report “Genetic Testing Market, Global Forecast By Type (Predictive Testing, Carrier Testing, Prenatal and New-born Testing, Diagnostic Testing, Pharmacogenomics Testing, Nutrigenomic Testing and Others), Technology (Cytogenetic Testing, Biochemical Testing and Molecular Testing), Application (Cancer, Genetic Diseases, Cardiovascular Diseases and Others), Region (Europe, America, Middle East & Africa and Asia-Pacific), Companies (Abbott Laboratories, Danaher Corporation (Cepheid Inc.), Illumina Inc., BioRad Laboratories Inc. and F Hoffmann-La Roche AG.)” provides a detailed analysis of Global Genetic Testing Market

Type - Genetic Testing Markethas been covered from 7 viewpoints:


1. Predictive Testing
2. Carrier Testing
3. Prenatal and New-born Testing
4. Diagnostic Testing
5. Pharmacogenomics Testing
6. Nutrigenomic Testing
7. Others

Technology - Genetic Testing Market has been covered from 3 viewpoints:


1. Cytogenetic Testing
2. Biochemical Testing
3. Molecular Testing

Application - Genetic Testing Market has been covered from 4 viewpoints:


1. Cancer
2. Genetic Diseases
3. Cardiovascular Diseases
4. Others

Region - Genetic Testing Market has been covered from 4 viewpoints:


1. Europe
2. America
3. Middle East & Africa
4. Asia-Pacific

Company Insights:

  • Overview
  • Recent Development & Strategies
  • Financial Insights

Company Covered:


1. Abbott Laboratories
2. Danaher Corporation (Cepheid Inc.)
3. Illumina Inc.
4. BioRad Laboratories Inc.
5. F Hoffmann-La Roche AG
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • BioRad Laboratories Inc.
  • F Hoffmann-La Roche AG
  • Illumina Inc.

1. Introduction2. Research Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Genetic Testing Market
6.1 By Type
6.2 By Technology
6.3 By Application
6.4 By Region
7. Type - Genetic Testing Market
7.1 Predictive Testing
7.2 Carrier Testing
7.3 Prenatal and New-born Testing
7.4 Diagnostic Testing
7.5 Pharmacogenomics Testing
7.6 Nutrigenomic Testing
7.7 Others
8. Technology - Genetic Testing Market
8.1 Cytogenetic Testing
8.2 Biochemical Testing
8.3 Molecular Testing
9. Application - Genetic Testing Market
9.1 Cancer
9.2 Genetic Diseases
9.3 Cardiovascular Diseases
9.4 Others
10. Region - Genetic Testing Market
10.1 Europe
10.2 America
11. Number of Labs by 47 Countries (Genetic Testing Registry)
12. Company Analysis
12.1 Abbott Laboratories
12.1.1 Overview
12.1.2 Recent Development
12.1.3 Financial Insights
12.2 Danaher Corporation (Cepheid Inc.)
12.2.1 Overview
12.2.2 Recent Development
12.2.3 Financial Insights
12.3 Illumina Inc.
12.3.1 Overview
12.3.2 Recent Development
12.3.3 Financial Insights
12.4 BioRad Laboratories Inc.
12.4.1 Overview
12.4.2 Recent Development
12.4.3 Financial Insights
12.5 F Hoffmann-La Roche AG
12.5.1 Overview
12.5.2 Recent Development
12.5.3 Financial Insights
List of Figures:
Figure-01: Global Genetic Testing Market (Billion US$), 2018 - 2021
Figure-02: Forecast for - Global Genetic Testing Market (Billion US$), 2022 - 2027
Figure-03: Type - Predictive Testing Market (Million US$), 2018 - 2021
Figure-04: Type - Forecast for Predictive Testing Market (Million US$), 2022 - 2027
Figure-05: Type - Carrier Testing Market (Million US$), 2018 - 2021
Figure-06: Type - Forecast for Carrier Testing Market (Million US$), 2022 - 2027
Figure-07: Type - Prenatal and Newborn Testing Market (Billion US$), 2018 - 2021
Figure-08: Type - Forecast for Prenatal and Newborn Testing Market (Billion US$), 2022 - 2027
Figure-09: Type - Diagnostic Testing Market (Billion US$), 2018 - 2021
Figure-10: Type - Forecast for Diagnostic Testing Market (Billion US$), 2022 - 2027
Figure-11: Type - Pharmacogenomic Testing Market (Million US$), 2018 - 2021
Figure-12: Type - Forecast for Pharmacogenomic Testing Market (Million US$), 2022 - 2027
Figure-13: Type - Nutrigenomic Testing Market (Million US$), 2018 - 2021
Figure-14: Type - Forecast for Nutrigenomic Testing Market (Million US$), 2022 - 2027
Figure-15: Type - Others Market (Million US$), 2018 - 2021
Figure-16: Type - Forecast for Others Market (Million US$), 2022 - 2027
Figure-17: Technology - Cytogenetic Testing Market (Billion US$), 2018 - 2021
Figure-18: Technology - Forecast for Cytogenetic Testing Market (Billion US$), 2022 - 2027
Figure-19: Technology - Biochemical Testing Market (Billion US$), 2018 - 2021
Figure-20: Technology - Forecast for Biochemical Testing Market (Billion US$), 2022 - 2027
Figure-21: Technology - Molecular Testing Market (Billion US$), 2018 - 2021
Figure-22: Technology - Forecast for Molecular Testing Market (Billion US$), 2022 - 2027
Figure-23: Application - Cancer Market (Billion US$), 2018 - 2021
Figure-24: Application - Forecast for Cancer Market (Billion US$), 2022 - 2027
Figure-25: Application - Genetic Diseases Market (Billion US$), 2018 - 2021
Figure-26: Application - Forecast for Genetic Diseases Market (Billion US$), 2022 - 2027
Figure-27: Application - Cardiovascular Diseases Market (Billion US$), 2018 - 2021
Figure-28: Application - Forecast for Cardiovascular Diseases Market (Billion US$), 2022 - 2027
Figure-29: Application - Others Market (Billion US$), 2018 - 2021
Figure-30: Application - Forecast for Others Market (Billion US$), 2022 - 2027
Figure-31: Europe - Genetic Testing Market (Billion US$), 2018 - 2021
Figure-32: Europe - Forecast for Genetic Testing Market (Billion US$), 2022 - 2027
Figure-33: America - Genetic Testing Market (Billion US$), 2018 - 2021
Figure-34: America - Forecast for Genetic Testing Market (Billion US$), 2022 - 2027
Figure-35: Middle East & Africa - Genetic Testing Market (Million US$), 2018 - 2021
Figure-36: Middle East & Africa - Forecast for Genetic Testing Market (Million US$), 2022 - 2027
Figure-37: Asia-Pacific - Genetic Testing Market (Billion US$), 2018 - 2021
Figure-38: Asia-Pacific - Forecast for Genetic Testing Market (Billion US$), 2022 - 2027
Figure-39: Abbott Laboratories - Global Revenue (Billion US$), 2018 - 2021
Figure-40: Abbott Laboratories - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure-41: Danaher Corporation (Cepheid Inc.) - Global Revenue (Billion US$), 2018 - 2021
Figure-42: Danaher Corporation (Cepheid Inc.) - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure-43: Illumina Inc. - Global Revenue (Billion US$), 2018 - 2021
Figure-44: Illumina Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure-45: BioRad Laboratories Inc. - Global Revenue (Billion US$), 2018 - 2021
Figure-46: BioRad Laboratories Inc. - Forecast for Global Revenue (Billion US$), 2022 - 2027
Figure-47: F Hoffmann-La Roche AG - Global Revenue (Billion US$), 2018 - 2021
Figure-48: F Hoffmann-La Roche AG - Forecast for Global Revenue (Billion US$), 2022 - 2027
List of Tables:
Table-01: Global - Genetic Testing Market Share by Type (Percent), 2018 - 2021
Table-02: Global - Forecast for Genetic Testing Market Share by Type (Percent), 2022 - 2027
Table-03: Global - Genetic Testing Market Share by Technology (Percent), 2018 - 2021
Table-04: Global - Forecast for Genetic Testing Market Share by Technology (Percent), 2022 - 2027
Table-05: Global - Genetic Testing Market Share by Application (Percent), 2018 - 2021
Table-06: Global - Forecast for Genetic Testing Market Share by Application (Percent), 2022 - 2027
Table-07: Global - Genetic Testing Market Share by Region (Percent), 2018 - 2021
Table-08: Global - Forecast for Genetic Testing Market Share by Region (Percent), 2022 - 2027
Table-09: Number of Labs by Countries (Genetic Testing Registry)
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Danaher Corporation (Cepheid Inc.)
  • Illumina Inc.
  • BioRad Laboratories Inc.
  • F Hoffmann-La Roche AG
Note: Product cover images may vary from those shown

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...